Literature DB >> 8416658

Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition.

M Ott1, B Lembcke, H Fischer, R Jäger, H Polat, H Geier, M Rech, S Staszeswki, E B Helm, W F Caspary.   

Abstract

Total body water, body fat, body cell mass (BCM), extracellular mass (ECM), and the ECM-BCM ratio by impedance analysis were determined in 193 human immunodeficiency virus (HIV)-infected patients and 340 control subjects. Walter Reed (WR) classification was WR 2 in 26, WR 3-5 in 85, and WR 6 in 82 patients. Whereas resistance was increased, reactance and the phase angle were significantly reduced in all patient groups. Neither body weight nor body mass index (BMI) was affected in WR 2 patients, but BCM was reduced (31.9 +/- 4.3 vs 35.8 +/- 7.3 kg, P < 0.007) and ECM (31.2 +/- 4.4 vs 28.8 +/- 3.8 kg) as well as ECM-BCM ratio increased (0.99 +/- 0.14 vs 0.83 +/- 0.16, P < 0.001). In contrast to WR classification, diarrhea did not correspond with malnutrition. A loss of BCM (malnutrition) occurred already in otherwise symptomless HIV-infected patients (WR 2). This effect can be measured by tetrapolar impedence analysis but not by body weight or BMI.

Entities:  

Mesh:

Year:  1993        PMID: 8416658     DOI: 10.1093/ajcn/57.1.15

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  12 in total

1.  Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease.

Authors:  M A McNurlan; P J Garlick; R T Steigbigel; K A DeCristofaro; R A Frost; C H Lang; R W Johnson; A M Santasier; C J Cabahug; J Fuhrer; M C Gelato
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Skeletal and cardiac myopathy in HIV-1 transgenic rats.

Authors:  Anne M Pruznak; Ly Hong-Brown; Rachel Lantry; Pengxiang She; Robert A Frost; Thomas C Vary; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-19       Impact factor: 4.310

3.  Assessment of body fat composition disturbances by bioimpedance analysis in HIV-infected adults.

Authors:  P Freitas; D Carvalho; A C Santos; J Mesquita; F Correia; S Xerinda; R Marques; E Martinez; A Sarmento; J L Medina
Journal:  J Endocrinol Invest       Date:  2011-07-05       Impact factor: 4.256

4.  Nutritional aspects of HIV-associated wasting in sub-Saharan Africa.

Authors:  John R Koethe; Douglas C Heimburger
Journal:  Am J Clin Nutr       Date:  2010-02-10       Impact factor: 7.045

5.  Resting energy expenditure and body composition in morbidly obese, obese and control subjects.

Authors:  S Verga; S Buscemi; G Caimi
Journal:  Acta Diabetol       Date:  1994-04       Impact factor: 4.280

6.  Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine.

Authors:  R Kinscherf; V Hack; T Fischbach; B Friedmann; C Weiss; L Edler; P Bärtsch; W Dröge
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

7.  Predicting body fatness: the body mass index vs estimation by bioelectrical impedance.

Authors:  R Roubenoff; G E Dallal; P W Wilson
Journal:  Am J Public Health       Date:  1995-05       Impact factor: 9.308

Review 8.  Growth and puberty in children with HIV infection.

Authors:  E S Majaliwa; A Mohn; F Chiarelli
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

9.  Serum Phosphate Predicts Early Mortality among Underweight Adults Starting ART in Zambia: A Novel Context for Refeeding Syndrome?

Authors:  John R Koethe; Meridith Blevins; Christopher K Nyirenda; Edmond K Kabagambe; Janelle M Chiasera; Bryan E Shepherd; Isaac Zulu; Douglas C Heimburger
Journal:  J Nutr Metab       Date:  2013-04-16

10.  HIV-1 infection and the PPARγ-dependent control of adipose tissue physiology.

Authors:  Marta Giralt; Pere Domingo; Francesc Villarroya
Journal:  PPAR Res       Date:  2008-12-01       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.